tirzepatide vs compounded semaglutide Troubling Findings in Study of GLP-1 Compounders are all semaglutide the same

Published 2021-5-11 Type 2 diabetes mellitus (T2DM) is closely associated with cardiovascular diseases (CVD), including atherosclerosis, hypertension and heart failure

I've had patients achieve excellent results with older, more affordable medications

7 Safety considerations and patient selection GLP-1 receptor agonists have a well-defined safety profile

Many posts described using smaller doses, including semaglutide microdosing, as a way to manage side effects, extend medication supply, or navigate access barriers

Retatrutide is an investigational triple agonist (GLP-1, GIP, glucagon) peptide injectable not yet licensed by the MHRA or EMA